Tyra Biosciences (TYRA) Shares Outstanding (2020 - 2026)

Tyra Biosciences has reported Shares Outstanding for 7 years, with the latest figure at $59.5 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 12.02% year-over-year to $59.5 million; the trailing twelve-month figure through Mar 2026 stood at $59.5 million (up 12.02% YoY), and the FY2025 full-year result was $53.7 million, up 5.83% from the prior year.
• Shares Outstanding for Q1 2026 stood at $59.5 million, up from $53.7 million in the prior quarter.
• The five-year high for Shares Outstanding was $59.5 million in Q1 2026, with the low at $45919.0 in Q3 2022.
• Historically, Shares Outstanding has averaged $43.3 million across 5 years, with a median of $50.7 million in 2024.
• Annual changes were most pronounced in 2022 — Shares Outstanding surged 1792.87% — and 2025, when it grew 0.84%.
• Tyra Biosciences' Shares Outstanding stood at $42.4 million in 2022, then advanced by 1.58% to $43.0 million in 2023, then climbed by 17.96% to $50.7 million in 2024, then gained by 5.83% to $53.7 million in 2025, then advanced by 10.73% to $59.5 million in 2026.
• The last three Shares Outstanding figures came in at $59.5 million (Q1 2026), $53.7 million (Q4 2025), and $53.3 million (Q3 2025), per Business Quant data.